Eton Pharmaceuticals, Inc. (ETON) Net margin 2019–2025
Eton Pharmaceuticals, Inc. (ETON) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.8%FY2025 · since FY2019: -1910.3% → -5.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.8% | +4.0 pp |
| FY2024 | -9.8% | -6.8 pp |
| FY2023 | -3.0% | +39.5 pp |
| FY2022 | -42.4% | -33.5 pp |
| FY2021 | -9.0% | +71709.0 pp |
| FY2020 | -71717.9% | -69807.6 pp |
| FY2019 | -1910.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Gross profitETON Gross marginETON Operating incomeETON Operating marginETON Operating cash flowETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →